Drugs for Rare Diseases (DRD)

Increasing timely access to medicines for patients suffering from rare diseases.

One in 12 Canadians, two-thirds of them children, suffer from a rare disease. IMC is committed to advocating for policies that increase timely access to medicines and treatments for patients suffering from rare diseases.

Canada desperately needs a rare disease strategy that’ll enable better patient care and access to treatment for those living with rare diseases.


Breaking down and analyzing current events in the healthcare industry for our members, policy influencers and the Canadian public.


Our member companies, which range from early-stage startups to established organizations, are revolutionizing healthcare through the discovery and development of new […]


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.